  Introduction: The goal of this paper is to study inequities in breast cancer
(BC) health care outcomes for Chilean women, including case fatality (FR) and
survival rates (SR), stratified by type of health care provider and
geographical area. A secondary goal is to estimate BC incidence (IR) and
mortality (MR) rates by health care providers and region. Methods: We used two
public anonymized databases provided by the Ministry of Health: the national
death and hospital discharges datasets. For survival analysis, we used the
Kaplan Meier product-limit estimator (KM) with a 95% ci and the Cox
proportional hazards model (CM) with null-hypothesis significance testing of
p>0.001. Results: We considered a cohort of 58,254 and 16,615 BC hospital
discharges and deaths for the period 2007-2018. New cases and deaths due to BC
increased by 43.6% and 33.6% respectively. Avg age-adjusted IR and MR were 44.0
and 10.5, respectively. Women affiliated to a private provider (ISAPRE) have an
avg age adjusted IR of 60.6 compared to 38.8 for women affiliated with the
public provider (FONASA). The national FR has remained constant over time, with
a mean of 26.8. Women affiliated with ISAPRE had a considerably lower FR during
the period under study, with an avg of 15.7 compared to 27.5 for women in
FONASA. The avg 5-year SR were 0.81 and 0.90 for FONASA and ISAPRE. Women from
the Metropolitan area have higher SRs than women from other regions. SRs
obtained using the CM have a similar behavior to those obtained by the KM.
Discussion: Despite the inclusion of BC in the GES plan in 2005 to provide
greater, there are still significant differences in FR and SR for patients
affiliated to ISAPRE compared to those in FONASA, a choice that is directly
associated with socioeconomic level, and for patients in the Metropolitan and
other regions. Further studies are required to determine the causes of these
disparities.
